MKI67 and central nervous system cancer: Considering the decrease of Ki67 index change in necrosis group and low-activity group, our results are also similar to Gzell et al. reported that change in Ki67 can predict survival in patients having repeat craniotomy within 6 months of radiotherapy for high-grade glioma [17].